Area of research
Biomedical Engineering · Surgery
Research interest
Research interests include Helicobacter pylori-related gastroenterology studies, Nanoplatforms for cancer theranostics, Advanced Drug Delivery Systems, and Microfluidic and Bio-sensing Technologies.
A digital nanoplasmonic microarray immunosensor for multiplexed cytokine monitoring during CAR T-cell therapy from a leukemia tumor microenvironment model
Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy
Coating Nanoparticles with Gastric Epithelial Cell Membrane for Targeted Antibiotic Delivery against <i>Helicobacter pylori</i> Infection
Micromotor-enabled active drug delivery for in vivo treatment of stomach infection
Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management
Micromotors Spontaneously Neutralize Gastric Acid for pH‐Responsive Payload Release
Enteric Micromotor Can Selectively Position and Spontaneously Propel in the Gastrointestinal Tract
Nanoparticle‐Based Antivirulence Vaccine for the Management of Methicillin‐Resistant <i>Staphylococcus aureus</i> Skin Infection
Nanoparticle biointerfacing by platelet membrane cloaking
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
RBC micromotors carrying multiple cargos towards potential theranostic applications
Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers
Hydrogel Retaining Toxin‐Absorbing Nanosponges for Local Treatment of Methicillin‐Resistant <i>Staphylococcus aureus</i> Infection
Mechanism of Antibacterial Activity of Liposomal Linolenic Acid against Helicobacter pylori
Cell Membrane-Coated Nanoparticles As an Emerging Antibacterial Vaccine Platform
Artificial Micromotors in the Mouse’s Stomach: A Step toward <i>in Vivo</i> Use of Synthetic Motors
Nanoparticle approaches against bacterial infections
Hydrogel Containing Nanoparticle-Stabilized Liposomes for Topical Antimicrobial Delivery
In vivo treatment of <i>Helicobacter pylori</i> infection with liposomal linolenic acid reduces colonization and ameliorates inflammation
Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infection
Antibacterial Activities of Liposomal Linolenic Acids against Antibiotic-Resistant <i>Helicobacter pylori</i>